First in-human modified atrial septostomy combining radiofrequency ablation and balloon dilation
Chaowu Yan, Linyuan Wan, Hua Li, Cheng Wang, Tingting Guo, Hanxu Niu, Shiguo Li, Pingcuo Yundan, Lei Wang, Wei Fang, Chaowu Yan, Linyuan Wan, Hua Li, Cheng Wang, Tingting Guo, Hanxu Niu, Shiguo Li, Pingcuo Yundan, Lei Wang, Wei Fang
Abstract
Objective: Preclinical research suggests that the combined use of radiofrequency ablation and balloon dilation (CURB) could create stable interatrial communications without device implantation. This study examined the first in-human use of CURB for modified atrial septostomy in patients with severe pulmonary arterial hypertension (PAH).
Methods: Between July 2018 and October 2021, CURB was performed in 19 patients with severe PAH (age: 31.5±9.1 years; mean pulmonary artery pressure: 73 mm Hg (IQR: 66-92); pulmonary vascular resistance: 18.7 Wood units (IQR: 17.8-23.3)). Under guidance of intracardiac echocardiography and three-dimensional location system, (1) fossae ovalis was reconstructed and ablated point-by-point with radiofrequency; (2) then graded balloon dilation was performed after transseptal puncture and the optimal size was determined according to the level of arterial oxygen saturation (SatO2); (3) radiofrequency ablation was repeated around the rims of the created fenestration. The interatrial fenestrations were followed-up serially.
Results: After CURB, the immediate fenestration size was 4.4 mm (IQR: 4.1-5.1) with intracardiac echocardiography, systolic aortic pressure increased by 10.2±6.9 mm Hg, cardiac index increased by 0.7±0.3 L/min/m2 and room-air resting SatO2 decreased by 6.2±1.9% (p<0.001). One patient experienced increased pericardiac effusion postoperatively; the others had no complications. On follow-up (median: 15.5 months), all interatrial communications were patent with stable size (intraclass correlation coefficient=0.96, 95%CI:0.89 to 0.99). The WHO functional class increased by 1 (IQR: 1-2) (p<0.001) with improvement of exercise capacity (+159.5 m, P<0.001).
Conclusion: The interatrial communications created with CURB in patients with severe PAH were stable and the mid-term outcomes were satisfactory.
Trial registration number: NCT03554330.
Keywords: Ablation Techniques; Cardiac Catheterization; Endovascular Procedures; Hypertension, Pulmonary.
Conflict of interest statement
Competing interests: None declared.
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9606506/bin/heartjnl-2022-321212f01.jpg)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9606506/bin/heartjnl-2022-321212f02.jpg)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9606506/bin/heartjnl-2022-321212f03.jpg)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9606506/bin/heartjnl-2022-321212f04.jpg)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9606506/bin/heartjnl-2022-321212f05.jpg)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9606506/bin/heartjnl-2022-321212f06.jpg)
References
- Rich S, Lam W. Atrial septostomy as palliative therapy for refractory primary pulmonary hypertension. Am J Cardiol 1983;51:1560–1. 10.1016/0002-9149(83)90678-1
- Micheletti A, Hislop AA, Lammers A, et al. . Role of atrial septostomy in the treatment of children with pulmonary arterial hypertension. Heart 2006;92:969–72. 10.1136/hrt.2005.077669
- Kurzyna M, Dabrowski M, Bielecki D, et al. . Atrial septostomy in treatment of end-stage right heart failure in patients with pulmonary hypertension. Chest 2007;131:977–83. 10.1378/chest.06-1227
- Sandoval J, Gaspar J, Peña H, et al. . Effect of atrial septostomy on the survival of patients with severe pulmonary arterial hypertension. Eur Respir J 2011;38:1343–8. 10.1183/09031936.00072210
- Khan MS, Memon MM, Amin E, et al. . Use of balloon atrial septostomy in patients with advanced pulmonary arterial hypertension: a systematic review and meta-analysis. Chest 2019;156:53–63. 10.1016/j.chest.2019.03.003
- Allcock RJ, O'Sullivan JJ, Corris PA. Atrial septostomy for pulmonary arterial hypertension. Heart 2003;89:1344–7. 10.1136/heart.89.11.1344
- Obokata M, Reddy YNV, Shah SJ, et al. . Effects of Interatrial Shunt on Pulmonary Vascular Function in Heart Failure With Preserved Ejection Fraction. J Am Coll Cardiol 2019;74:2539–50. 10.1016/j.jacc.2019.08.1062
- Danial P, Dupont S, Escoubet B, et al. . Pulmonary haemodynamic effects of interatrial shunt in heart failure with preserved ejection fraction: a preclinical study. EuroIntervention 2020;16:434–40. 10.4244/EIJ-D-18-01100
- Lauder L, Pereira TV, Degenhardt MC, et al. . Feasibility and efficacy of transcatheter interatrial shunt devices for chronic heart failure: a systematic review and meta-analysis. Eur J Heart Fail 2021;23:1960–70. 10.1002/ejhf.2360
- Baylen BG, Grzeszczak M, Gleason ME, et al. . Role of balloon atrial septostomy before early arterial switch repair of transposition of the great arteries. J Am Coll Cardiol 1992;19:1025–31. 10.1016/0735-1097(92)90288-X
- McQuillen PS, Hamrick SEG, Perez MJ, et al. . Balloon atrial septostomy is associated with preoperative stroke in neonates with transposition of the great arteries. Circulation 2006;113:280–5. 10.1161/CIRCULATIONAHA.105.566752
- Gopalakrishnan A, Sasidharan B, Krishnamoorthy KM, et al. . Left ventricular regression after balloon atrial septostomy in d-transposition of the great arteries. Eur J Cardiothorac Surg 2016;50:1096–101. 10.1093/ejcts/ezw206
- Sandoval J, Gaspar J, Pulido T, et al. . Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension. A therapeutic alternative for patients nonresponsive to vasodilator treatment. J Am Coll Cardiol 1998;32:297–304. 10.1016/s0735-1097(98)00238-1
- Moscucci M, Dairywala IT, Chetcuti S, et al. . Balloon atrial septostomy in end-stage pulmonary hypertension guided by a novel intracardiac echocardiographic transducer. Catheter Cardiovasc Interv 2001;52:530–4. 10.1002/ccd.1116
- Kerstein D, Levy PS, Hsu DT, et al. . Blade balloon atrial septostomy in patients with severe primary pulmonary hypertension. Circulation 1995;91:2028–35. 10.1161/01.CIR.91.7.2028
- Althoff TF, Knebel F, Panda A, et al. . Long-term follow-up of a fenestrated Amplatzer atrial septal occluder in pulmonary arterial hypertension. Chest 2008;133:283–5. 10.1378/chest.07-1222
- Danon S, Levi DS, Alejos JC, et al. . Reliable atrial septostomy by stenting of the atrial septum. Catheter Cardiovasc Interv 2005;66:408–13. 10.1002/ccd.20508
- Troost E, Delcroix M, Gewillig M, et al. . A modified technique of stent fenestration of the interatrial septum improves patients with pulmonary hypertension. Catheter Cardiovasc Interv 2009;73:173–9. 10.1002/ccd.21760
- Hasenfuß G, Hayward C, Burkhoff D, et al. . A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (reduce LAP-HF): a multicentre, open-label, single-arm, phase 1 trial. Lancet 2016;387:1298–304. 10.1016/S0140-6736(16)00704-2
- Shah SJ, Feldman T, Ricciardi MJ, et al. . One-year safety and clinical outcomes of a transcatheter interatrial shunt device for the treatment of heart failure with preserved ejection fraction in the reduce elevated left atrial pressure in patients with heart failure (reduce LAP-HF I) trial: a randomized clinical trial. JAMA Cardiol 2018;3:968–77. 10.1001/jamacardio.2018.2936
- Kaye DM, Petrie MC, McKenzie S, et al. . Impact of an interatrial shunt device on survival and heart failure hospitalization in patients with preserved ejection fraction. ESC Heart Fail 2019;6:62–9. 10.1002/ehf2.12350
- Rajeshkumar R, Pavithran S, Sivakumar K, et al. . Atrial septostomy with a predefined diameter using a novel occlutech atrial flow regulator improves symptoms and cardiac index in patients with severe pulmonary arterial hypertension. Catheter Cardiovasc Interv 2017;90:1145–53. 10.1002/ccd.27233
- Amat-Santos IJ, Del Trigo M, Bergeron S, et al. . Left atrial decompression using unidirectional left-to-right interatrial shunt: initial experience in treating symptomatic heart failure with preserved ejection fraction with the W-Wave device. JACC Cardiovasc Interv 2015;8:870–2. 10.1016/j.jcin.2015.02.009
- Simard T, Labinaz M, Zahr F, et al. . Percutaneous Atriotomy for Levoatrial-to-Coronary Sinus Shunting in Symptomatic Heart Failure: First-in-Human Experience. JACC Cardiovasc Interv 2020;13:1236–47. 10.1016/j.jcin.2020.02.022
- Guerrero M, Cajigas H, Awdish R, et al. . First-in-man experience with cryoplasty during graded balloon atrial septostomy to reduce spontaneous closure in a patient with severe pulmonary arterial hypertension. EuroIntervention 2014;9:1235–6. 10.4244/EIJV9I10A206
- Yan C, Niu G, Niu H, et al. . Stable interatrial communication combining balloon atrial septostomy and radiofrequency catheter ablation. J Am Coll Cardiol 2018;72:1873–5. 10.1016/j.jacc.2018.07.058
- Yan C, Pan X, Wan L, et al. . Combination of F-ASO and targeted medical therapy in patients with secundum ASD and severe PAH. JACC Cardiovasc Interv 2020;13:2024–34. 10.1016/j.jcin.2020.04.027
- Bourier F, Duchateau J, Vlachos K, et al. . High-power short-duration versus standard radiofrequency ablation: insights on lesion metrics. J Cardiovasc Electrophysiol 2018;29:1570–5. 10.1111/jce.13724
- Wakamatsu Y, Nakahara S, Nagashima K, et al. . Hot balloon versus cryoballoon ablation for persistent atrial fibrillation: lesion area, efficacy, and safety. J Cardiovasc Electrophysiol 2020;31:2310–8. 10.1111/jce.14646
- Kuck KH, Brugada J, Fürnkranz A. Fire and ice Investigators. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med 2016;374:2235–45.
Source: PubMed